SIADH with chronic mild-to-moderate hyponatraemia requiring oral sodium chloride tablets
Oral sodium chloride tablets are not recommended as initial therapy in SIADH. [1] Fluid restriction should be used first-line in moderate or profound hyponatraemia due to SIAD. [1] Oral sodium chloride can be considered only as part of second-line measures when hyponatraemia remains unresolved despite fluid restriction, with the guideline listing “low-dose loop diuretics and oral sodium chloride” as an equal second-line option for moderate or profound hyponatraemia. [1]
Medication selection algorithm
Medication selection for chronic SIADH should follow a cause-specific treatment framework. [1]
Second-line solute strategies for moderate or profound SIAD include the following options: [1]
- Increased solute intake with urea at 0.25–0.50 g/kg per day (oral). [1]
- A combination of low-dose loop diuretics and oral sodium chloride. [1]
Key evidence supporting this recommendation
A randomized controlled study (EFFUSE-FLUID trial) in SIAD patients with baseline serum sodium ≤130 mmol/L found no significant between-group difference in serum sodium correction at day 4 and no significant difference across groups in the proportion achieving sodium thresholds by study timepoints when comparing fluid restriction alone versus fluid restriction plus furosemide plus NaCl (NaCl 3 g/day). [2] Adverse effects were more common with the furosemide-containing regimens. [2]
Monotherapy versus combination therapy
Oral sodium chloride should not be used as the sole “add-on” strategy before failure of fluid restriction when the guideline second-line option is explicitly framed as “low-dose loop diuretics and oral sodium chloride.” [1] In SIAD, fluid restriction remains the first-line intervention. [1]
Important clarifications and nuances
For mild hyponatraemia, the guideline suggests against treatment with the sole aim of increasing serum sodium concentration. [1] Accordingly, initiation of oral sodium chloride is less supported when the clinical intent is only to raise serum sodium in the setting of mild hyponatraemia. [1]
Initiation thresholds or indications
Oral sodium chloride tablets should be considered after fluid restriction failure or unresolved hyponatraemia when the clinical classification is moderate or profound SIAD, because fluid restriction is recommended first-line and low-dose loop diuretic plus oral sodium chloride is listed as an equal second-line option. [1]
Common pitfalls to avoid
Oral sodium chloride should not be started as first-line therapy in SIADH because the guideline recommends fluid restriction first-line in moderate or profound SIAD. [1] Oral sodium chloride should not be used with a sole goal of increasing serum sodium concentration in mild hyponatraemia. [1]
Target blood pressure goals
No blood pressure targets are specified for SIADH-directed oral sodium chloride initiation in the cited guideline text; the management targets in SIAD relate to correction limits and biochemical monitoring rather than antihypertensive goals. [1]
Practical “when to start” determination for the presented patient profile
If hyponatraemia is mild and neurological symptoms are absent, oral sodium chloride tablets should not be initiated solely to increase serum sodium concentration. [1] If hyponatraemia is classified as moderate or profound and remains unresolved despite fluid restriction, oral sodium chloride tablets can be considered as part of second-line therapy with low-dose loop diuretics. [1]